Variables for the bromeliad agent representing a single <i>T. utriculata</i> rosette. by Alexandra M. Campbell (3284094)

Subjects:

Variables of patch located at coordinates . by Alexandra M. Campbell (3284094)

Subjects:

MRSP Tree Host Data. by Alexandra M. Campbell (3284094)

Subjects:

<i>Tillandsia utriculata</i> death rate data by size class. by Alexandra M. Campbell (3284094)

Subjects:

Histograms of (A) distance measured in meters to nearest neighboring tree given bin widths of 2 m (<i>n</i> = 44), and (B) basal areas of all sampled trees (<i>n</i> = 58; bin widt... by Alexandra M. Campbell (3284094)

Subjects:

Parameter sets generated through Latin hypercube sampling. by Alexandra M. Campbell (3284094)

Subjects:

Lifespan of a single <i>T. utriculata</i> rosette. by Alexandra M. Campbell (3284094)

Subjects:

Thioflavin-T (ThT) fluorescence analysis of amyloid fibril formation in wild-type and p.R163C mutant αB-crystallin under thermochemical stress. by Aref Baharvand (21713886)

Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Data Sheet 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 3_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Patient characteristics before and after propensity score matching. by Anna D. Ware (19688153)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects:

Unadjusted and adjusted odds ratios (95% confidence interval) for associations between patients who were prescribed aspirin at baseline and the occurrence of post-COVID-19 acute th... by Anna D. Ware (19688153)

Subjects:

Forest plot displaying the association (odds ratio [95% CI]) between patients who were prescribed aspirin at baseline and the occurrence of post-COVID-19 acute thromboembolic disor... by Anna D. Ware (19688153)

Subjects:

Patient flowchart. by Anna D. Ware (19688153)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects: